PATENT CLAIM ANALYSIS

Application Number: 15753994
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["435", "006140"]

Abstract:
The object of the invention is to elucidate a new causative gene of cancer, polynucleotide, and thereby provide a method for detecting the polynucleotide or a polypeptide that is encoded by the polynucleotide, as well as a primer set or a detection kit for such detection. The detection method detects a fusion gene of a part of an RP2 gene and a part of an ARHGAP6 gene, or a fusion protein encoded by such gene. The primer set includes a sense primer designed from a section encoding RP2 and an antisense primer designed from a section encoding ARHGAP6.

Claim (Index 7):
The method according to  claim 5  comprising a step of amplifying the nucleic acid existing in a sample obtained from a subject using a primer set shown below:\n a primer set for detecting a fusion gene composed of an RP2 gene and an ARHGAP6gene, wherein a sense primer consists of an oligonucleotide of at least 16 random consecutive bases between base no. 1 to 102 of SEQ ID NO: 1, and an antisense primer consists of an oligonucleotide complementary to an oligonucleotide of at least 16 random consecutive bases between base no. 103 to 2439 of SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 2.1875
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15753775', '14383199', '13805513', '15113599', '14643181']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.600870876924838
- 35 USC 102 Novelty (BERT): 0.5378413912457992
- Combined Prediction Score: 0.5945679283569341
- Mean Citation Score: 345.207742
- Max Citation Score: 374.71338
- Similarity Product: 318.9912226877188

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test